Deregulated activation of tyrosine kinase receptors in epithelial tumors, including RCC, represents an important mechanism that cancer cells adopt to promote the growth and invasiveness potential of malignant lesions. The gene discussed is NTRK1; the disease is renal cell carcinoma.